Article Details

Tampa biopharma firm focused on a cure for Alzheimer's disease raises $14.4M

Retrieved on: 2021-07-12 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Tampa biopharma firm focused on a cure for Alzheimer's disease raises $14.4M. View article details on hiswai:

Excerpt

(NASDAQ: ALZN), a pre-clinical stage biopharmaceutical company dedicated to developing products for neurodegenerative diseases and psychiatric ...

Article found on: stpetecatalyst.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up